{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:11:06Z","timestamp":1778749866668,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274158"],"award-info":[{"award-number":["82274158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M773923"],"award-info":[{"award-number":["2025M773923"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A04J5398"],"award-info":[{"award-number":["2025A04J5398"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZZYSM202206005"],"award-info":[{"award-number":["SZZYSM202206005"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prp.2026.156476","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:32:31Z","timestamp":1776493951000},"page":"156476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Icaritin inhibits castration-resistant prostate cancer via RhoB-mediated Akt signaling"],"prefix":"10.1016","volume":"283","author":[{"given":"Chen","family":"Hui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Yingyao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156476_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-024-02095-8","article-title":"Programmed death receptor (PD-)1\/PD-ligand (L)1 in urological cancers: the \"all-around warrior\" in immunotherapy","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156476_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156476_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","article-title":"Epidemiology and genomics of prostate cancer in Asian men","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2026.156476_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189033","article-title":"Targeting tumor and bone microenvironment: novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis","volume":"1879","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156476_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-319-99286-0_7","article-title":"Castration-resistant prostate cancer: mechanisms, targets and treatment","volume":"1096","author":"Mansinho","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2026.156476_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216759","article-title":"Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors","volume":"588","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156476_bib7","article-title":"Icaritin: a novel natural candidate for hematological malignancies therapy","volume":"2019","author":"Yang","year":"2019","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.prp.2026.156476_bib8","article-title":"Icariin as a potential anticancer agent: a review of its biological effects on various cancers","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.prp.2026.156476_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2023.113772","article-title":"Icaritin: a phytomolecule with enormous pharmacological values","volume":"213","author":"Huong","year":"2023","journal-title":"Phytochemistry"},{"key":"10.1016\/j.prp.2026.156476_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1074\/jbc.M311325200","article-title":"Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling","volume":"279","author":"Chauhan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156476_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1871530320666200531141455","article-title":"Gene therapy for prostate cancer: a review","volume":"21","author":"Talkar","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.prp.2026.156476_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","article-title":"Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer","volume":"21","author":"Gu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156476_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032046","article-title":"AR and PI3K\/AKT in prostate cancer: a tale of two interconnected pathways","volume":"24","author":"Tortorella","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156476_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.apsb.2021.06.009","article-title":"miR-7\/TGF-\u03b22 axis sustains acidic tumor microenvironment-induced lung cancer metastasis","volume":"12","author":"Su","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.prp.2026.156476_bib15","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15382.1","article-title":"Recent trends in the management of advanced prostate cancer","volume":"7","author":"Ritch","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.prp.2026.156476_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.prp.2026.156476_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049887","article-title":"Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target","volume":"7","author":"Tsai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156476_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12885-025-13762-4","article-title":"RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway","volume":"25","author":"Sheng","year":"2025","journal-title":"BMC Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:27:15Z","timestamp":1778747235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"alternative-id":["S0344033826001299"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156476","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icaritin inhibits castration-resistant prostate cancer via RhoB-mediated Akt signaling","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156476"}}